Haleos Labs Limited share price
NSE: HALEOSLABS · ISIN INE320X01016
Key numbers
- Market cap
- ₹ 454 Cr
- Current price
- ₹ 1,501.80
- 52-week high / low
- ₹ 1,774 / 1,091
- Stock P/E
- 28.7
- Book value
- ₹ 705.8
- Dividend yield
- 0.10%
- ROCE
- 10.3%
- ROE
- 8.4%
- Debt to equity
- 0.52
- Sales growth (3 yrs)
- 0.3%
- Profit growth (3 yrs)
- 14.7%
- 1-year return
- 26.8%
About Haleos Labs Limited
Haleos Labs Limited engages in the manufacturing of active pharmaceutical ingredients (API) and intermediates in India. The company offers API and intermediates in areas, such as anti-ulcer, anti-migraine, anti-hypertensive, erectile dysfunction, anti-cancer, antifungal, anti-obesity, anti-emetic, anti-depressant, anti-worm, anti-infective, anti-gout, anti-convulsant, antiviral, and anesthesia, as well as antihistamine, diuretics, hair loss, and ophthalmic API products. It also export its products. The company was formerly known as SMS Lifesciences India Limited and changed its name to Haleos Labs Limited in August 2025. Haleos Labs Limited was founded in 1990 and is based in Hyderabad, India.
Quarterly results
Consolidated figures in ₹ crores
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales | 83 | 81 | 95 | 75 | 73 |
| Operating profit | 12 | 14 | 14 | 4 | 9 |
| Net profit | 4 | 6 | 7 | 0 | 3 |
| EPS (₹) | 13.75 | 20.19 | 21.89 | 1.44 | 8.75 |
Peers in Biotechnology
Data for information only, not investment advice. Prices end of day.